Synthetic prion Peptide 106-126 resulted in an increase matrix metalloproteinases and inflammatory cytokines from rat astrocytes and microglial cells. - Wikidata - wikimedia - TriplyDB

Synthetic prion Peptide 106-126 resulted in an increase matrix metalloproteinases and inflammatory cytokines from rat astrocytes and microglial cells.

Synthetic prion Peptide 106-126 resulted in an increase matrix metalloproteinases and inflammatory cytokines from rat astrocytes and microglial cells.

http://www.wikidata.org/entity/Q37326320

about

Modulation of Inflammatory Cytokines and Islet Morphology as Therapeutic Mechanisms of in Streptozotocin-Induced Diabetic Rats

P2860

Q58125927-59EAEC19-8F4C-4B9C-818A-17112894066E

P2860

Synthetic prion Peptide 106-126 resulted in an increase matrix metalloproteinases and inflammatory cytokines from rat astrocytes and microglial cells.

http://www.wikidata.org/entity/Q37326320

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2012

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Synthetic prion Peptide 106-12 ...... trocytes and microglial cells.

@en

Synthetic prion Peptide 106-12 ...... trocytes and microglial cells.

@nl

type

label

Synthetic prion Peptide 106-12 ...... trocytes and microglial cells.

@en

Synthetic prion Peptide 106-12 ...... trocytes and microglial cells.

@nl

prefLabel

Synthetic prion Peptide 106-12 ...... trocytes and microglial cells.

@en

Synthetic prion Peptide 106-12 ...... trocytes and microglial cells.

@nl

P1433

Q37326320-C99CC4D5-1195-4F89-9B61-D8DDDDB08BA9

P1476

Q37326320-2799794B-D746-4178-B137-E7865CA71803

P2093

Q37326320-163E7068-CC94-4FEE-8321-AEE21A84AD84

Q37326320-22D61525-41C2-4429-ACCE-0BC03D7EA5D4

Q37326320-262B3E68-20E1-4E84-B456-2709365379A5

Q37326320-6B95C696-1DC6-41BB-8329-E6FA3A531A83

Q37326320-94E5E9AA-007E-4C3E-A427-5EDC7072EF97

Q37326320-BFAF06F1-69E9-48CD-8F0C-16915071FC20

Q37326320-D65770D2-F59F-449E-BA99-5A8E6A9728F5

Q37326320-DF55108A-6AA3-44BF-B2D6-D2B00B1C18F2

Q37326320-F11E81FF-3770-44EE-B855-646CBE6271BE

Q37326320-F2A1D812-C40B-48C0-9DCC-F596EC6E6858

P2860

Q37326320-012C8226-9EE5-4712-AF2C-ECC5A024871D

Q37326320-1E3451BE-F9D9-4E37-BD8C-D08CBD0853F4

Q37326320-394A7748-8AB3-41E4-84D1-2BE5A0A211C5

Q37326320-4204A558-1C02-4729-BFFD-6AB6E0E691C9

Q37326320-4BF58A15-34DE-4473-9380-6AF7E28972D0

Q37326320-67348167-24A3-40DF-B900-1D91A6D2AA35

Q37326320-73643C57-FAE1-431F-B8F9-C0992FC0BED9

Q37326320-7A3430D5-6F83-4DDD-B60A-0D7C0BBDD7AD

Q37326320-98049609-30DB-4BCF-A69A-6F9110B5909B

Q37326320-9E08AC42-F52B-4833-AEB1-F3B41A05158A

P304

Q37326320-41CBDFDD-1825-451A-92DF-8ED81033A31B

P31

Q37326320-004005BE-B4CE-4FE9-9D30-65BF6261049B

P356

Q37326320-121EFAF2-7453-433E-80ED-001BCFBE30B5

P433

Q37326320-A18CDE55-67FD-42A1-8446-C329FE55FFF0

P478

Q37326320-5BF9B375-8A49-4127-B4C4-288B9AC50CDA

P577

Q37326320-67F65EF5-390E-4D20-A081-922E97576C8D

P698

Q37326320-9240CF26-2AE1-409C-B9EA-EA6973BDA59F

P921

Q37326320-2C2CD5F7-C83A-4F64-BCF9-48731BE1C9A5

Q37326320-45C5D110-2382-4847-A6F6-2594F8D568EA

Q37326320-ee834b4e-3f42-41f7-b835-6bd889288f95

P932

Q37326320-A0C8E78F-0F8D-4C9F-B642-FDEE4B785432

P356

TR.2012.28.1.005

P1433

Toxicological research

P1476

Synthetic prion Peptide 106-12 ...... trocytes and microglial cells.

@en

P2093

Bumseok Kim

http://www.w3.org/2001/XMLSchema#string

Byung-Yong Park

http://www.w3.org/2001/XMLSchema#string

Gi-Wook Shin

http://www.w3.org/2001/XMLSchema#string

Ji-Young Na

http://www.w3.org/2001/XMLSchema#string

Jungkee Kwon

http://www.w3.org/2001/XMLSchema#string

Kibbeum Song

http://www.w3.org/2001/XMLSchema#string

Myung-Hoon Oh

http://www.w3.org/2001/XMLSchema#string

Myungjo You

http://www.w3.org/2001/XMLSchema#string

Sokho Kim

http://www.w3.org/2001/XMLSchema#string

Young-Ha Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Blood-brain barrier disruption by stromelysin-1 facilitates neutrophil infiltration in neuroinflammation

The neurotoxic prion peptide fragment PrP(106-126) is a chemotactic agonist for the G protein-coupled receptor formyl peptide receptor-like 1.

Glial activation in Alzheimer's disease: the role of Abeta and its associated proteins.

The TIMPs tango with MMPs and more in the central nervous system.

Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states.

A novel method to establish microglia-free astrocyte cultures: comparison of matrix metalloproteinase expression profiles in pure cultures of astrocytes and microglia

A novel intracellular role of matrix metalloproteinase-3 during apoptosis of dopaminergic cells.

Matrix metalloproteinase-3: a novel signaling proteinase from apoptotic neuronal cells that activates microglia.

Cell and agonist-specific regulation of genes for matrix metalloproteinases and their tissue inhibitors by primary glial cells.

Relationship of microglia and scrapie amyloid-immunoreactive plaques in kuru, Creutzfeldt-Jakob disease and Gerstmann-Sträussler syndrome.

P304

5-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5487/TR.2012.28.1.005

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2012-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24278583

http://www.w3.org/2001/XMLSchema#string

P921

Prion protein family

P932

3834397

http://www.w3.org/2001/XMLSchema#string